Carcinoid Syndrome and Perioperative Anesthetic Considerations Kenneth Mancuso MD (Assistant Professor)A, Alan D
Journal of Clinical Anesthesia (2011) 23, 329–341 Review article Carcinoid syndrome and perioperative anesthetic considerations Kenneth Mancuso MD (Assistant Professor)a, Alan D. Kaye MD, PhD (Professor, Chairman)a, J. Philip Boudreaux MD, FACS (Professor)b,c, Charles J. Fox MD (Associate Professor)d,e, Patrick Lang (Medical Student)e, Philip L. Kalarickal MD, MPH (Clinical Assistant Professor)f, Santiago Gomez MD (Clinical Assistant Professor)f, Paul J. Primeaux MD (Clinical Assistant Professor)g,⁎ aDepartment of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA bDivision of Neuroendocrine Surgery and Transplantation, Louisiana State University Health Sciences Center, New Orleans, LA cChairman, Department of Surgery, Ochsner-Kenner Hospital, Kenner, LA 70065, USA dDirector of Perioperative Management, Department of Anesthesiology, Tulane University School of Medicine, New Orleans, LA 70112, USA eTulane University School of Medicine, New Orleans, LA 70112, USA fDepartment of Anesthesiology, Tulane University School of Medicine, New Orleans, LA 70112, USA gResidency Program Director, Department of Anesthesiology, Tulane University School of Medicine, New Orleans, LA 70112, USA Received 10 February 2010; revised 7 December 2010; accepted 8 December 2010 Keywords: Abstract Carcinoid tumors are uncommon, slow-growing neoplasms. These tumors are capable of Carcinoid syndrome; secreting numerous bioactive substances, which results in significant potential challenges in the Octreotide; management of patients afflicted with carcinoid syndrome. Over the past two decades, both surgical and Serotonin medical therapeutic options have broadened, resulting in improved outcomes. The pathophysiology, clinical signs and symptoms, diagnosis, treatment options, and perioperative management, including anesthetic considerations, of carcinoid syndrome are presented. © 2011 Elsevier Inc.
[Show full text]